Federal award (BPA CALL, fiscal year 2024)
Recipient: SUN PHARMACEUTICAL INDUSTRIES, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-01-08 to 2025-09-30
Current total value of award: $21834
Description: RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE.